STOCKS TELEGRAPH

Category: Investing

  • Rules Of Day Trading: Can I Buy a Stock and Sell It the Next day?

    Rules Of Day Trading: Can I Buy a Stock and Sell It the Next day?

    Conservatism generally entails purchasing stocks and holding them for a longer period and even years, hoping that overall market upward trends will benefit them. Stock markets allow investors to do the day trading, or they can buy today and profit tomorrow. Buying and selling securities in a day or few days period is normally called Short-Term trading. A short-term trade is also dubbed as swing trading and refers to the holding of a position (long or short) for only a short period of time. In this article, we will discuss both day trading and the rules of day trading.

    Why Rules of Day Trading are the key?

    In this practice, traders buy and sell stocks on the same day in an attempt to profit from daily fluctuations in stock prices. The price of a share of stock may rise from $35.50 to $35.60 in a few minutes, and the trader will turn a profit of 10 cents per share. In the case of a price decrease later in the day, when the stock price falls to $35.50, the trader may buy more shares in anticipation of a price increase. All that can be done efficiently only if the rules of the day trading are followed.

    Day trading rules help cut the risk of loss

    Short-Term traders run the risk of losing all their profits because daily stock price fluctuations can’t be predicted. It is a short-term bet on stock prices that makes Short-Term traders unique. Although they can win big sometimes, they can lose very quickly as well. Lots of Short-Term traders experience severe financial losses, and many never succeed in making profits as they don’t follow the basic rules of day trading.

    Short-term traders may make money, but their tax rates are often higher than those for long-term investors. Taxes are payable on capital gains realized from the sale of stock. The maximum capital gains tax rate for stocks owned over a year is 15%.

    Stocks that are held for less than a year are taxed at the same rate as income taxes. It means that traders can be taxed at rates as high as 35% on short-term trading gains.

    To trade successfully with this strategy must understand the risks and rewards. Short-term traders should have a thorough understanding of several concepts to succeed. Trading can be successful if the basics are put right.

    By knowing which trades are ideal, traders will be able to discern between a good deal and a bad deal. There are many investors who get caught up at the moment and think that they know what’s happening in the markets if they read the financial pages or watch the evening news. In reality, when the news breaks, the market has already reacted. For this reason, it is important to follow some basic steps to find the right trades at the right time.

    What are Rules Of Day Trading

    Observing closely the Moving Averages

    This is the very first rule of day trading. Stocks have moving averages whenever they have been traded over a given time frame. In general, 15-, 20-, 30-, 50-, 100-, and 200-day time frames are most common. This indicator shows whether an asset is trending upwards or downwards. Moving averages with an upward slope are generally considered good candidates. The general rule when looking for a good stock to short is to find one whose moving average is falling or flattening.

    Observing Overall Cycles or Patterns

    Most markets go through phases, so it is essential to track the calendar at particular times. Historically, the stock market has gained most during the November to April time frame, while the May to October period has experienced relatively stable averages. It is possible to determine the best times to enter long or short positions using cycles as a trader.

    Get a Sense of Market Trends

    A negative trend may prompt you to consider shorting rather than buying. If the trend is positive, you might consider buying with minimal shorting. During a trend-reversed market, your chances of making a successful trade decrease. Keeping these steps in mind will enable traders to recognize potential trades and how to spot them.

    Better Risk Assessment

    Another rule of successful day trading begins with a better risk assessment. It is crucial to maximize return and minimize risk when trading short-term. A sell stop or a buy stop serves as a safeguard against market reversals. When a stock reaches a predetermined price, then a sell stop is triggered. Once this price is reached, the order is executed. Buy stops are the opposite of sell stops. In a short position, it becomes a buy order when the stock rises to a certain price.

    In both cases, you are limiting your downside. For short-term trading, it is generally recommended that your sell stop or buy stop be set within 10% to 15% of your original price. In order to be able to achieve substantial gains, you need to keep losses manageable.

    Buy and Sell Indicators

    To decide the right time to buy and sell, various indicators are used. There are two popular ones: the relative strength index (RSI) and the stochastic oscillator. A stock’s RSI shows how strong or weak it is in comparison with other stocks on the market. If the reading is over 70, it shows the stock is in a topping pattern, and if it is below 30, it shows the stock is oversold.

    In any case, keep in mind that prices can remain overbought or oversold for quite some time.

    Based on the stock’s closing price over a period of time, the stochastic oscillator lets you know whether it’s cheap or expensive. Readings of 80 indicate an overbought (expensive) stock, whereas readings of 20 indicate an oversold (cheap) stock.

    Stock-picking tools like RSI and stochastics can be useful, but they should be used in conjunction with other approaches to identify the best opportunities.

    Finally,

    Money can be made through a variety of methods and tools used in short-term trading. It is in fact possible to Invest today and Profit tomorrow, but it is important to understand how to apply the tools to achieve that success. Depending on the particular tendencies and risk appetite, traders are likely to gravitate toward one or more strategies as they learn more about short-term trading. The goal of any trading strategy is to follow the rules of day trading by keep losses at a minimum and profits at a maximum, and this is no different for short-term trading.

  • Best Stocks Under to Buy Now

    Best Stocks Under $1 to Buy Now

    Stocks under $1 have a reputation to be speculative investments and the trade trends of these penny stocks are volatile.

    Investors make a sizable number of investments in stocks under a dollar based on speculations and hope that the volatility of the stock trend shifts in their favor.

    Penny stock investors burn a lot of their investment due to volatility. They also lose a lot of money due to poor decision-making behind the investment – now this is because penny stocks are often subjected to pump-and-dump plays by investors.

    What Are Penny Stocks?

    Penny stocks are low-priced, speculative securities traded outside major exchanges.

    Typically valued at less than $5 per share, they represent small companies with high growth potential but also heightened volatility and risk.

    Where To Buy Penny Stocks

    Penny stocks can be purchased through various online brokerage platforms or over-the-counter markets.

    It’s essential to research reputable brokers and understand the associated fees and risks before investing.

    Why Penny Stocks Under $1?

    Penny stocks under $1 are considered ultra-speculative due to their affordability and potential for substantial gains.

    Investors are enticed by the opportunity to buy large quantities with limited capital, but this also magnifies the risk of significant losses.

    The Risky Business of Penny Stocks

    Investing in penny stocks carries substantial risks for their low liquidity, lack of financial history, and vulnerability to manipulation.

    It makes them a breeding ground for fraud and pump-and-dump schemes.

    Novice investors must exercise caution and conduct thorough due diligence before diving in.

    List of Penny Stocks Under $1

    Here are the 5 best stocks under 1 to buy now:

      • Castellum, Inc. (NYSE: CTM) 

        Castellum, Inc. (CTM) emerges as a noteworthy candidate in our list of top stocks under $1 to buy now, offering strong growth potential.

        The company specializes in cybersecurity, electronic warfare, and software engineering solutions tailored for federal government contracts.

        With the increasing demand for advanced digital security, Castellum is well-positioned to capitalize on this expanding sector.

        Currently, Castellum’s stock is trading at approximately $0.76, with a market capitalization of $61.45 million.

        Over the past year, it has seen an impressive 169.46% gain, reflecting investor confidence.

        Additionally, its earnings per share (EPS) have climbed by 63.76% year-over-year, showcasing steady financial progress.

        In December 2024, Castellum successfully raised $3.7 million through a public offering of over 4.3 million shares at $0.85 per share.

        These funds are earmarked for corporate expansion and operational improvements.

        Moreover, a strategic alliance formed in mid-2024 with Krilla Kaleiwahea, LLC (K2), a Native Hawaiian Organization, opens new doors for securing federal defense contracts valued at up to $100 million.

        The broader cybersecurity market is undergoing rapid transformation, with increasing mergers and acquisitions expected in 2025.

        Major firms are consolidating to strengthen their market position, creating opportunities for agile players like Castellum to expand through new partnerships and government contracts.

        Additionally, the rise of artificial intelligence (AI) in cybersecurity is reshaping the industry, with a growing need for sophisticated digital protection against evolving threats.

        Given its upward trajectory, strategic partnerships, and favorable industry trends, Castellum, Inc. presents a promising investment opportunity for those looking to capitalize on stocks priced under $1.

      • Northern Dynasty Minerals Ltd. (NYSE: NAK)

        The second stock in the list of best stocks under $1 is – Northern Dynasty Minerals Ltd. (NAK).

        It is a Vancouver-based company specializing in mineral exploration and development.

        Its primary asset is the Pebble Mine project in southwest Alaska, known for its vast reserves of copper, gold, molybdenum, silver, and rhenium.

        Spanning approximately 274 square miles with around 1,840 mineral claims, this project positions the company within a crucial segment of the mining industry.

        Currently, Northern Dynasty Minerals has a market capitalization of $348.23 million, with its stock trading at $0.625 per share.

        Over the past year, the stock has surged by 169.83%, highlighting increasing investor interest.

        The company also maintains an average 90-day trading volume of 3.56 million shares, reflecting active market participation.

        Northern Dynasty’s subsidiary, Pebble Partnership, this month agreed to a 90-day pause at the request of the Environmental Protection Agency (EPA), allowing for further review of the project’s future.

        Earlier in the month, the company reassured investors with an open letter detailing progress and reaffirming its commitment to advancing the Pebble Mine.

        The broader mining industry, especially the copper sector, is experiencing strong demand due to the global shift toward renewable energy and electric vehicles.

        Copper’s role in electrical infrastructure places companies like Northern Dynasty in a favorable position.

        NAK’s ongoing engagement with regulators and its resilient market performance suggest potential for future growth.

        The significant upside prospect led us to add this stock to our list of best stocks under a dollar.

        Those looking for promising growth potentials, Northern Dynasty Minerals remains a noteworthy option.

      • Ocean Power Technologies, Inc. (NYSE: OPTT) 

        Next on our list is a Monroe Township, New Jersey-based penny stock known as Ocean Power Technologies (OPTT)

        OPTT is a key player in the marine energy sector, providing advanced low-carbon power and data solutions.

        The company specializes in intelligent maritime technologies, serving industries such as defense, offshore wind, oil and gas, and scientific research.

        One of its standout offerings is the PowerBuoy system, a wave energy converter that supports offshore operations with renewable energy.

        Additionally, OPTT’s Merrows platform integrates artificial intelligence to enhance maritime domain awareness across various applications.

        Currently, OPTT’s stock trades at approximately $0.6537, holding a market capitalization of $96.92 million and has demonstrated an impressive one-year growth rate of 134.71%.

        In the second quarter of fiscal year 2025, OPTT generated $2.4 million in revenue, a 2.7x increase from the previous year, while its earnings per share (EPS) saw a year-over-year gain of 39.87%.

        The broader marine renewable energy industry is experiencing strong momentum, with governments worldwide prioritizing sustainability initiatives.

        The United Kingdom recently introduced policies aimed at streamlining offshore wind development, extending financial incentives to energy companies, and expediting regulatory approvals.

        Such measures highlight the increasing global investment in renewable energy, positioning Ocean Power Technologies for long-term success for promising metrics and growth in its fundamentals.

        With the increasing focus on sustainability and clean energy, OPTT’s stock presents an attractive opportunity for investors seeking exposure to the growing marine technology sector.

        This makes OPTT a phenomenal among cheap stocks to buy now under $1 dollar.

        These last two stocks are also worth watching over the next few weeks.

      • Origin Materials Inc. (NASDAQ: ORGN)

        Next on our list is Origin Materials Inc. (ORGN), a technology company dedicated to facilitating the global shift toward sustainable materials.

        With a market capitalization of approximately $135.98 million and a current stock price of $0.9398, the company has demonstrated a notable 79.32% improvement in its one-year performance.

        The sustainable materials sector is experiencing significant growth, driven by increasing environmental awareness and regulatory pressures.

        With a size of over $200 billion in 2024 and the sector is projected to reach $367.2 billion by 2029.

        However, the industry faces challenges, including scrutiny over the true environmental benefits of bioplastics and the need for more robust recycling infrastructures.

        In its latest financials, Origin Materials reported revenue of $8.2 million, primarily from its supply chain activation program.

        A significant milestone was the successful Factory Acceptance Test of their first CapFormer System, achieving over 98% manufacturing efficiency.

        This system is poised to produce PET caps, with revenue generation anticipated in the first quarter of 2025.

        The company plans to deploy at least eight CapFormer Systems by the end of 2025, aiming for a production capacity of 8 to 12 billion caps annually.

        Given the company’s advancements and strategic positioning within a burgeoning industry, high-risk investors might find Origin Materials a compelling opportunity for potential future gains.

      • Tiziana Life Sciences, Ltd. (Nasdaq: TLSA)

        Tiziana Life Sciences (TLSA), headquartered in London, UK, is a clinical-stage biopharmaceutical company pioneering innovative therapies through advanced drug delivery technologies, focusing on alternative immunotherapy routes.

        With a current price of $0.8806, the company has a market capitalization of approximately $104.86 million.

        Over the past year, TLSA has demonstrated a robust performance, with its market cap increasing by 65.96%.

        Tiziana recently regained compliance with Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market.

        This compliance underscores the company’s commitment to adhering to regulatory standards and maintaining investor confidence.

        Financially, Tiziana has adopted a disciplined approach, securing non-dilutive funding to strengthen its balance sheet, thereby facilitating the progression of clinical trials and expansion of research and development capabilities.

        The biopharmaceutical manufacturing market size is poised for significant growth in 2025 to $539 billion from $467 billion in 2024.

        It is also anticipated to reach around $1.79 trillion by 2034, driven by advancements in drug development and strategic collaborations.

        Notably, Western pharmaceutical companies are increasingly partnering with Chinese firms to develop and commercialize “super me-too” drugs, aiming to enhance treatment efficacy for diseases such as obesity and cancer.

        This trend reflects a dynamic shift in the industry, emphasizing the importance of innovative therapies and strategic alliances.

        Tiziana’s lead candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, is currently undergoing a Phase 2a clinical trial for non-active secondary progressive multiple sclerosis.

        The intranasal delivery method is designed to modulate T cell function, potentially offering a more effective and tolerable treatment option compared to traditional intravenous therapies.

        The U.S. Food and Drug Administration has granted Fast Track designation for foralumab, expediting its development and review process.

        Given the company’s innovative approach, recent regulatory achievements, and the favorable industry landscape, Tiziana Life Sciences presents a compelling opportunity for investors seeking exposure to the biopharmaceutical sector.

        However, potential investors should conduct thorough due diligence and remain cognizant of the inherent volatility associated with clinical-stage biotech stocks.

    We have also compiled here a list of best potential stocks under $1:

    No Ticker Company Name Industry ST Score Market Cap Price Analyst Rating
    1 VGZ Vista Gold Corp. Gold 54 77.35 M 0.628 Buy
    2 MKTW MarketWise, Inc. Software – Application 51 192.94 M 0.595 Buy
    3 AMRN Amarin Corporation plc Biotechnology 49 242.27 M 0.589 Buy
    4 FGEN FibroGen, Inc. Biotechnology 48 71.13 M 0.706 Buy
    5 PXLW Pixelworks, Inc. Semiconductors 47 47.47 M 0.806 Buy
    6 UNCY Unicycive Therapeutics, Inc. Biotechnology 46 64.03 M 0.617 Buy
    7 FURY Fury Gold Mines Limited Industrial Materials 45 59.16 M 0.391 Buy
    8 RVSN Rail Vision Ltd. Railroads 45 13.37 M 0.665 Buy
    9 TOI The Oncology Institute, Inc. Medical – Care Facilities 45 67.24 M 0.890 Buy
    10 ARBB ARB IOT Group Limited Information Technology Services 43 12.76 M 0.483 Buy
    11 CARM Carisma Therapeutics, Inc. Biotechnology 43 18.80 M 0.450 Buy
    12 CNTX Context Therapeutics Inc. Biotechnology 43 61.05 M 0.814 Buy
    13 IMAB I-Mab Biotechnology 43 74.71 M 0.970 Buy
    14 MRNS Marinus Pharmaceuticals, Inc. Biotechnology 43 30.37 M 0.550 Buy
    15 VFF Village Farms International, Inc. Agricultural Farm Products 43 88.04 M 0.784 Buy
    16 ZOM Zomedica Corp. Drug Manufacturers – Specialty & Generic 43 117.40 M 0.120 Buy
    17 PED PEDEVCO Corp. Oil & Gas Exploration & Production 42 68.03 M 0.760 Buy
    18 LUNA Luna Innovations Incorporated Hardware, Equipment & Parts 40 27.76 M 0.800 Buy
    19 SPRO Spero Therapeutics, Inc. Biotechnology 40 45.30 M 0.831 Buy
    20 XTNT Xtant Medical Holdings, Inc. Medical – Devices 40 77.84 M 0.560 Buy

    Penny Stock Strategies

    Penny stocks, low-priced equities typically traded outside major exchanges, have garnered both fascination and skepticism in the financial world.

    While these stocks offer the allure of astronomical gains, they come with substantial risks.

    As such, investors should approach them with caution and adopt specific strategies to optimize their chances of success.

    Penny Stock Strategies

    • Diligent Research and Due Diligence

      Thorough research is paramount when dealing with penny stocks. Investigate the company’s fundamentals, financials, and management team.

      Scrutinize market trends and industry outlooks to make informed decisions.

      By performing due diligence, you can identify viable opportunities from possible scams in order to safeguard your investment.

    • Risk Management and Diversification

      Due to their volatile nature, penny stocks can be highly unpredictable. Employ risk management techniques like stop-loss orders to protect your capital from significant losses.

      Diversifying your portfolio across various industries can mitigate risk and balance potential rewards.

    • Technical Analysis for Entry and Exit Points

      Utilize technical analysis to identify suitable entry and exit points. Analyzing price charts and patterns can assist in timing trades, optimizing gains, and minimizing losses.

    • Avoiding Emotional Trading

      Stay rational and avoid emotional trading. Penny stocks’ rapid price fluctuations may trigger impulsive decisions, leading to regrettable outcomes.

      Adopt a disciplined approach and stick to a well-defined strategy.

    How To Trade Penny Stocks

    While Penny stocks can be enticing due to their low entry costs and potential for rapid gains, they also carry significant risks.

    To trade penny stocks effectively, conduct thorough research on companies, focusing on financials and potential catalysts.

    Develop a disciplined strategy and stick to it, avoiding impulsive decisions. Diversify your portfolio to mitigate risks and set clear entry and exit points.

    Stay updated with market trends and news to make informed choices.

    Penny Stock Rules

    Before delving into penny stock trading, it is essential to understand the rules that govern these volatile securities. Some key rules include:

    • Research Extensively

      Penny stocks often lack sufficient information, making thorough research critical. Analyze company fundamentals, financials, news, and market trends before investing.

    • Limit Orders Are Crucial

      Due to high volatility, place limit orders instead of market orders to control the price at which you buy or sell penny stocks.Penny Stock Rules

    • Diversify Your Portfolio

      Avoid putting all your funds into a single penny stock. Diversification can help mitigate risk.

    • Be Cautious Of Pump And Dump Schemes

      Beware of fraudulent practices where scammers artificially inflate stock prices before selling their shares.

    • Understand Market Trends

      Keep an eye on overall market trends and industry performance to make informed decisions.

    How To Find Stocks Under $1

    Finding penny stocks with potential requires a systematic approach. Here are some methods to identify these stocks:

    • Screening Tools

      Utilize stock screening tools and platforms that allow you to filter stocks based on specific criteria, including price, market capitalization, and volume.

    • Stock News and Websites

      Follow financial news outlets and websites that focus on penny stocks. They often highlight companies with promising prospects.

    • Social Media and Forums

      While it’s essential to be cautious, social media platforms and online forums may offer insights into trending penny stocks.

    • Company Filings

      Access the SEC’s EDGAR database to examine a company’s financial reports and disclosures.

    Pros And Cons of Stocks Under $1

    Trading penny stocks comes with advantages and disadvantages. Understanding these can help you make informed decisions:

    Pros
    Low Entry Cost Penny stocks allow investors with limited capital to enter the stock market.
    High Growth Potential Some penny stocks experience exponential growth, providing significant returns.
    Volatility Opportunities Rapid price movements present opportunities for short-term traders.

     

    Cons
    High Risk Penny stocks are highly volatile and can lead to substantial losses.
    Lack of Information Many penny stock companies have limited publicly available information, making due diligence challenging.
    Liquidity Concerns Low trading volumes can result in difficulties when buying or selling large quantities.

    Top Platforms to Trade Best Stocks Under $1

    Selecting the right trading platform is crucial for successful penny stock trading. Some popular platforms that offer access to best stocks under 1 include:

    Top Platforms to Trade Best Stocks Under $1

    • Robinhood

      Known for its user-friendly interface and commission-free trading, Robinhood is favored by many beginner traders.

    • E-Trade

      With a wide range of investment options and research tools, E-Trade caters to both beginners and experienced traders.

    • TD Ameritrade

      This platform offers a variety of educational resources and advanced trading tools.

    • Fidelity

      Fidelity is a well-established platform that provides access to penny stocks alongside other investment products.

    Should You Invest in Penny Stocks?

    Deciding whether to invest in penny stocks depends on your risk tolerance, investment goals, and trading experience. Consider the following factors before making a decision:

    • Risk Tolerance: If you can withstand significant volatility and potential losses, penny stocks may be an option.
    • Experience: Penny stocks are not recommended for novice investors due to their complexity.
    • Diversification: Never allocate your entire portfolio to penny stocks. Maintain a diversified investment approach.
    • Long-Term Vs. Short-Term: Determine whether you are a long-term investor or a short-term trader.

    List of the Best Stocks Under $10

    Although we have comprehensively discussed various cheap stocks to buy now under $1 dollar to consider investment in, listed below are the best performing stocks under $10 that you can get in the market:

    No Ticker Company Name Industry ST Score Market Cap Price Analyst Rating
    1 CLNE Clean Energy Fuels Corp. Oil & Gas Refining & Marketing 43 625.68 M 2.8 Strong Buy
    2 MLSS Milestone Scientific Inc. Medical – Instruments & Supplies 45 81.01 M 1.04 Strong Buy
    3 MRAM Everspin Technologies, Inc. Semiconductors 41 130.29 M 5.93 Strong Buy
    4 OBE Obsidian Energy Ltd. Oil & Gas Exploration & Production 45 455.27 M 5.99 Strong Buy
    5 THTX Thera Technologies Inc. Drug Manufacturers – Specialty & Generic 64 84.83 M 1.84 Buy
    6 CHR Cheer Holding, Inc. Advertising Agencies 62 27.52 M 2.68 Buy
    7 BCRX BioCryst Pharmaceuticals, Inc. Biotechnology 61 1.91 T 9.21 Buy
    8 FINV FinVolution Group Financial – Credit Services 61 2.24 T 8.52 Buy
    9 MITT AG Mortgage Investment Trust, Inc. REIT – Mortgage 60 218.96 M 7.42 Buy
    10 DCGO DocGo Inc. Medical – Care Facilities 58 488.82 M 4.79 Buy

    Features to Look for in Best Stocks Under $10

    Whether you are looking for hot stocks to buy under $10 or are simply interested in stocks under one dollar, it is important to focus your sights on a number of features regarding the particular stocks.

    Each of the stocks mentioned in this article, including the stocks under $1, hold these features within them:

    • Growth Potential

      Look for companies with strong growth potential that are likely to increase their revenue and earnings over time.

      This can be indicated by positive earnings growth, expanding margins, and increasing market share.

    • Attractive Valuation

      Consider stocks that are reasonably priced relative to their earnings, cash flow, and other metrics.

      Avoid companies that appear to be overvalued or have a high price-to-earnings ratio. This is true for stocks under $1.

    • Competitive Strengths

      Select stocks of companies with a competitive advantage, such as a unique product or service, a strong brand, or proprietary technology.

      These companies are better positioned to maintain their market position and continue to grow over time.

    • Financial Stability

      Look for companies with solid financials, including a healthy balance sheet, low debt levels, and positive cash flow.Financial Stability - Cash Flows

      Companies with strong financials are better able to weather economic downturns and other challenges, even for stocks under $1.

    Conclusion

    Exploring the world of best stocks under $1 can be a rewarding venture for investors seeking potential growth opportunities.

    These low-priced stocks often present the chance to enter burgeoning markets or emerging companies with significant upside potential.

    However, it is crucial to approach such investments with caution and thorough research.

    Due to their inherent volatility and speculative nature, a diversified portfolio strategy is recommended to mitigate risks.

    Investors should remain focused on long-term growth prospects, keeping an eye on the fundamentals of the companies in question.

    While these stocks may carry higher risk, their potential for substantial returns can be enticing for those willing to embrace a calculated approach to their investment journey.

    FAQs

    How Can I Invest $1000 In Penny Stocks?

    Investing $1000 in penny stocks can be a high-risk, speculative endeavor.

    Conduct thorough research on the companies you’re interested in, considering their financial health and growth potential.

    Diversify your portfolio to reduce risk, and set stop-loss orders to protect your investment. Stay disciplined and avoid impulsive decisions. Seek advice from financial experts if uncertain.

    Is Investing In Stocks Under $1 Profitable?

    Investing in stocks under $1 can be alluring due to their affordability, but it carries significant risks.

    While some may see explosive gains, many low-priced stocks are highly volatile and susceptible to manipulation.

    Prudent investors should exercise caution, conduct thorough research, and diversify their portfolios to mitigate potential losses.

    Why Do Most Penny Stocks Fail?

    Most penny stocks fail due to their inherent risks and speculative nature. Often associated with small, volatile companies, they lack financial stability and regulatory scrutiny.

    Their low prices attract inexperienced investors seeking quick gains, leading to inflated demand and subsequent crashes.

    Limited liquidity, poor fundamentals, and susceptibility to manipulation contribute to the high failure rate.

    Do Penny Stocks Ever Go Big?

    Penny stocks, though highly speculative, hold the potential to skyrocket. Unpredictable market forces can propel them to exponential growth, turning small investments into significant returns.

    However, caution is advised due to their inherent volatility, susceptibility to scams, and lack of liquidity. Diligent research and risk management are crucial for success.

  • What Are Meme Stocks and Their Trading Practice?

    What Are Meme Stocks and Their Trading Practice?

    The term “meme stock” is not uncommon these days for keen stock market followers. If you are unsure of what a meme stock is, allow us to explain to you what it is: it is a stock that goes viral through online propagation, causing a short squeeze in its price.

    In a process of a short squeeze, a stock is heavily shorted following a piece of sudden positive news or a catalyst that brings in lots of new buyers. Short sellers are now forced to cover their positions (getting squeezed out), resulting in more buying, thus causing the stock to surge quickly and significantly.

    Meme stocks have grown in popularity over the past few years. The soaring share price of GameStop (GME) in January 2021 became a highly publicized event. Users of WallStreetBets have picked up GME stock after hedge funds disclosed they are shorting it.

    Online discussion forums and social media platforms are usually responsible for meme stock’s price rise, rather than factors like production growth. The value of these stocks typically increases rapidly, so they become overvalued.

    So, how good are they for investment

    In most cases, meme stocks aren’t a good investment option; they are better classified as growth or value stocks, as their price volatility and hype may not correspond with realistic valuations.

    For instance, In recent times, there are several meme stocks to choose from, such as GameStop, AMC, and BlackBerry. After being mentioned on a popular Reddit forum, all three stocks shot up at price despite their poor performance in recent years. AMC stock jumped almost tenfold in value, while BlackBerry stock rose almost three times. However, neither of them achieved the same level of viral success as GameStop, which raised hundreds of dollars over a few days.

    What made these Meme Stocks so popular?

    The popularity of meme stocks is usually fueled by social media conversations. Their prices tend to spike more frequently in relation to internet virality. Reddit’s WallStreetBets forum recently contributed to the spikes in meme stocks prices.

    In the recent 12 months, people stayed home following the pandemic, which resulted in significant layoffs. Besides all this free time, online platforms such as Robinhood and Webull have made investing more attractive. For retail investors, the marketplace was more widely accessible than ever before.

    Collectively, all these factors boosted meme stock popularity.

    Now let’s examine what creates meme crazes

    Because of the growth of retail investing in meme stocks, the concept has become increasingly relevant recently. Individual stock trading is now easier than ever, which means more people are taking part in this meme stock bursts. These artificial spikes are not really connected to the actual performances of the companies, sharp nose dives usually follow them. 

    There are various phases in the meme stock cycle.

    1. To start with, Short squeezed or undervalued stocks are purchased in large quantities by investors as soon as they notice them. All eyes are drawn to the stock price as it gradually increases.
    2. At this point, investors have noticed a rise in volumes. As more individuals buy the stock, its price skyrockets.
    3. Instantly, the stock’s status flashes up on Facebook, Twitter, and online discussion boards.
    4. As a result, more retail investors are motivated to invest, leading to FOMO (fear of missing out).
    5. After early adopters sell their early versions for a profit, this type of trading comes to a dramatic end. People worry about losing money on the selling side of the transaction just as they did during the buying phase. This is when prices plummet even faster than they rose.

    Who is the winner in Meme stock trading?

    The early adopters are the ones who stand to benefit most from meme stock trading. It is normally too late to reap the benefits for anyone who gets involved during the FOMO phase. The influence of Reddit and Twitter over the market in the past few months is testimony to this.

    Finally,

    Meme’s stock definition can’t be as simple as easy as a growth or value stock, so categorizing it definitely would be slightly misleading. Meme stock impact is unlikely to be incorporated into textbooks soon, but to ignore it could prove very costly.

  • Best EV Stocks to Buy Now

    Best EV Stocks to Buy Now

    When we talk about the Electric Vehicle or the EV stock market, what’s the first thing that pops into your mind? Tesla Inc (TSLA) might be the company that comes to your mind if you have kept up with the mainstream trends around EV. That’s because we have heard about Tesla as the world leader and pioneer of the electric vehicle market.

    And we have heard about Elon Musk, the CEO of Tesla, who launched the TESLA Roadster into space as one of the most phenomenal marketing tactics ever. And if you have heard of Tesla, chances are, you have heard about the Chinese EV company NIO that is fiercely competing and trying to emerge as an EV leader in China.

    However, if you are looking to invest in the EV market, you need to take few steps back from what the mainstream topics and trends are telling you. According to a new market research report, the EV market is growing and is only in the nascent stage despite being a $1656.9 billion worth global market. The EV market is expected to grow at a compound annual growth rate of 33.6% from 2020 to $2495.4 billion in 2027.

    Before we dive into the top EV stocks you can invest in let’s take a look at what is driving the growth of these EV stocks.

    Researching the few fundamentals and variables driving this growth in the EV market can help us a long way in deciding how and which EV stock we should invest in.

    So the main phenomenon that is driving the Electric Vehicle market includes the global drive towards green energy and sustainable zero emissions. Governments and world leaders are creating favorable policies and regulations regarding EV adoption. The free market has played a role in reducing the cost of sourcing batteries. The OEMs are investing heavily to create a profitable business in the EV landscape.

    However, there are some caveats to this growth. The scalability and standardization of the EV market are fragmented in countries and regions of the developed part of the world. The development of EV infrastructure and favorable economic conditions are yet to be globalized. Furthermore, there are very different EV portfolios in the EV stock market based on the electric vehicle and propulsion type of the EV.

    Ford Motor Company (F)

    So let us begin now with the EV stocks! The first on our list is Ford Motor Company (F). We have chosen Ford because of its legendary reputation in the car industry and its shift towards Electric Vehicles. With a market of $58.6 billion, Ford has a diverse and robust strategy for the electrification of its automotive operations. The company’s recent Ford+ (plus) plans expect to generate almost half of its global sales through EV by 2030.

    Furthermore, the company aims to invest more than $30 billion through 2025. One other primary reason that makes Ford’s EV portfolio more attractive is that the company has revealed its three most iconic EV products, which include the elite sports and passenger vehicle- The Mustang Mach E, all-electric and available in the market. Then comes the F-150 Lightning series, which is an all-electric pickup truck. This vehicle caters to the class B vehicle segment. And third is E-transit, an all-electric van that caters to the fleet performance requirement and light commercial vehicle segment.

    This diverse portfolio, along with the Ford company’s scalability power, will allow it to carry its powerful ICE automotive reputation while switching its profitability through the EV market.

    NIU Technologies (NIU)

    The second stock on our list is known as NIU Technologies (NIU). It has a market cap of $2.454 Billion and has seen impressive growth for the past two years. The company, since its inception, had grown in value by roughly 250% since its IPO in October 2018. We chose NIU stock for our pick in the top growing EVs because it picks up a certain niche in the large addressable market of EVs. This niche corresponds to the manufacturing of electric smart scooters and pedal bikes and is a less crowded market with many potentials. NIU caters explicitly to this niche demand in one of the largest growing EV markets: China.

    NIU generated sales of around $85.6 million in the first quarter, which is a 135% year-over-year growth. Despite the dip in the EV market in May, NIU also lost 10.8% of its stock value, and it still sold 149,649 electric scooters in Q1. Out of which 97% of the sales came from the Chinese market. NIU stock has a compound annual growth rate of 7.7% for the next decade, and despite the growing competition, it is still expanding to the rest of the Chinese market.

    Hyliion Holdings Corporation (HYLN)

    Third, on our list is an eccentric EV stock called Hyliion Holdings Corporation (HYLN). It is a $1.964 billion company run by a 28-year-old CEO known as Thomas Healy. Last year, the company went public through a SPAC deal with Tortoise, and since then, it had seen volatility in price during 2020, fluctuating from $10 to $50 and back to $10. However, we chose HYLN stock because this company caters to the deficiencies and limitations in the EV market that we talked about. The charging station and ports availability limitation makes it hard for EV vehicles to sustain their range, especially for Heavy-Duty trucks or Class 8 trucks.

    Thomas Healy has taken a page from Elon Musk’s book and has turned this limitation into an opportunity for innovation and drive towards a niche. This niche specifically caters to the needs of the 8th Class trucks by transforming them into what Hyliion calls Electrified Powertrains.

    Electrified Powertrains is the concept where Hybrid energy engines power class 8 trucks; they are electric engines that also have backup natural or hydrogen gas generators for creating electricity. Its EV battery next-generation module with quicker recharging and 40% more effective battery cooling technology reflects growth and innovation in its Hypertruck ERX production line. Hyliion took this approach to bridge the gap between the lack of electric recharging availability and heavy-duty trucks’ long-range requirements.

    With 700 natural gas stations all over America, according to Hyliion, this is a better approach than consuming gasoline and more efficient than having full electric trucks with no range. According to the company, the niche has a total addressable market of $800 billion and 8 million trucks.

    For the year 2021 and beyond, there are bullish signals for the EV market. Hyliion will continue to flourish in this underdeveloped niche market as long as EV charge and range limitation exists. The company’s estimation of revenue growth from $8 million in 2021 to more than $2 billion in 2024 does not look far-fetched from this point of view.

    NIO Inc (NIO)

    Fourth on our list is NIO Inc (NIO). The market value of the company is 83.410 Billion. Yes, we did mention NIO stock as a mainstream stock initially, but the growth of this EV company is uniquely undeniable and is stealing Tesla’s thunder. Analysts, bureaucrats, and even Elon Musk admitted that China is expected to be the biggest market for Tesla, with 41% of China’s global EV market share. However, the recent US-China relations have deteriorated.

    The rug has been pulled from under Tesla as China has recently implemented bans on government authorities having ownership of Tesla and banned Tesla vehicles from government compounds and agencies. This leaves the Chinese market all for NIO to grab since no one takes the throne second in China.

    Moreover, the company is entering the Norwegian Market as well; thus, now expanding and growing far beyond its border. The sales of the Chinese EV champion have leaped over 95% year over year and have forecasted 21000-22000 EV car deliveries from the current quarter. Apart from the general trend and sentiment of the EV market’s growth, NIO enjoys an edge for the market share capacity and space given due to these geopolitical tensions. Bloomberg NEF believes that EV sales are expected to grow from 1.7 million in 2020 to 54 million in 2040, in which China would represent sales share accounting 18 million.

    Global X Autonomous & Electric Vehicles ETF (DRIV)

    The final EV pick on our list is an ETF known as Global X Autonomous & Electric Vehicles ETF (DRIV). This ETF was picked by us majorly for investors out there that want to dive into the EV stocks but don’t know where to start. This $900 million market cap of DRIV ETF gives a diversified exposure to investors in the EV market. It has a total deep portfolio of 76 stocks and has an expense ratio of approximately 0.68%.

    DRIV does not only consist of pure Electric Vehicle play but consists of the overall plug-in car play. Plug-ins mean that it includes Autonomous Vehicles, Hydrogen Fuel Cars, Hybrids; therefore, it depends on the EV fuel propulsion and reduces the volatility and limitation of the EV pure-play investment and market. The Price to Equity ratio shows a very reduced premium compared to the over 900% increased share prices of Tesla and NIO. DRIV has shown a CAGRof 23.76% since its initiation.

  • What Are Biotech Stocks And How To Invest In Them

    What Are Biotech Stocks And How To Invest In Them

    In this article, we are going to help you understand everything there is about biotech companies ranging from what they are- all the way to- how to invest in biotech stocks. This will help you hit the nail on the head with the trend analysis and strategically make investments in this type of stock.

    Biotech stocks have been in the public’s portfolio right since the inception of the stock market and exchange platforms. But just like the recent surge in Green Energy stocks, EV stocks, and Crypto stocks, we are seeing a new rise and shift in the Biotech stocks’ popularity.

    This both excites the investors as well as creates curiosity over what actually is prompting the rise in biotech company stocks and biotech stock prices. This curiosity is essential for looking into the reasons why the Biotech stocks are trending and analyzing the patterns which are making this type of stock boom. This gives investors and stock analysts an edge in predicting and identifying signals and hints in the market shifts due to internal and external reasons.

    What are biotech stocks?

    Biotech Stocks are essentially publicly traded companies that focus on the development, production, and commercialization of pharmaceutical products and services that are used in the treatment of diseases. The therapeutics and treatments that you consume or apply in daily life, acquiring from pharmacies or hospital dispensaries exist because a Biotech company developed them.

    From a stock perspective, the biotech stock value ranges from triple-digit share prices all the way to under $1 price per share. The ones that are under $5 share prices are known as biotech penny stocks. These, just like every other penny stock are attributed to a lot of volatility however Biotech stocks have their own intrinsic share of volatility and risks (which come along with rewarding outcomes as well). Before we get into that let us first explain what really is creating the hype in this kind of stock, in the first place.

    How Biotech Industry became very popular among investors

    We mentioned before that the trend in the biotech stock is growing as it is in Green energy, Crypto, and EV stocks. But the reason behind this trend is completely different and associated to unique factors.

    Covid-19 Pandemic

    One major reason for the rise is the COVID-19 pandemic, specifically the race for vaccine production. When the pandemic had gripped the world in its virus, it had paralyzed many markets and business; the overall global economy was halted. In fact, even the most successful biotech companies had been forced to shut down. But Pandemic being human health and medical crisis had prompted responses from the very biotech industry that it had halted. The Biotech industry decided to push for solutions to the Pandemic and the virus, in the form of Vaccines. The vaccines became a huge market space in the healthcare industry and biotech stocks immediately started filling it up.

    The aging population

    According to the Rural Health Information Hub, The US population has more than 46 million citizens above or at the age of 65 which is expected to grow to 90 million almost in 2050. Every one in five Americans will be aged over 65 years old. The context of this is important when you correlate the use of prescribed medicines and drugs with old age; the older population uses prescribed medicines and drugs more often to treat their chronic illnesses and complications, as compared to younger generations. This means demand and innovation required from the Biotech Companies will increment in the following years and push the companies to focus on targeting innovative and niche spaces in the pharmaceutical market as competition concentrate between biotech companies.

    Exposure to Biotech stock

    The former factor is a more prevalent cause of exposure in the biotech market in the current market trend than the latter because the US and the overall world economy is slowly coming out of the Pandemic and rolling out vaccines. The pandemic had crippled many portfolios for the investors in various stocks and companies. During this time, the biotech stock was prevailing due to public, government, and private investors nudging the biotech companies to create vaccinations. This made investment profiles in the Biotech stock especially the ones in the vaccination race, more attractive.

    What are the types of Biotech Stocks?

    Now that we have established the roots of the developing trend in the Biotech industry, let’s focus on what exactly are the cues to look for when you are investing in the Biotech companies stock.

    There are three main types of Biotechnology companies; Medical, Agriculture, and industrial ( or referred to as Red, Green, and White respectively).

    The primary thing to focus on when you invest in Biotech companies is to have a bird’s eye view of all the metric and indicator for the stages and process that are related to Biotech stock’s operations/performances. This helps ensure, that your investment decision is based on solid evidence that can hopefully turn out to be incredibly rewarding.

    Biotech operations and drug development, especially in the Medical type, goes through rigorous testing that are subject to stringent approvals and regulatory standards. These operations, based on the development and approval are broken down into 5 stages.

    Investment and the five stages of Biotech Stock operations

    The first stage of drug development is known as Research and Discovery, where concepts and theories of new products are formed along with a given conceptual framework to back up the attributes and potential of the new product.

    The second stage is known as Preclinical Stage, where the drug’s pharmacological profile is created to assess the strategies and planning of human testing and effects that are expected to result from the early and late clinical stages. This profile is assessed by the regulatory bodies like the US FDA, to be approved and taken to the next stage human trials and tests. These trials and tests take place in 4 phases;

    • Phase 1: The safety of the drug is evaluated in human trials with determination to predict dosage range.
    • Phase 2: The efficacy of the drug is tested relevant to the disease it is targeting. This phase is known as proof of concept (PoC).
    • Phase 3: The proof of concept and previous phases are tested again in large population batches with several thousand people. This phase is known as regulatory proof which when approved requires the next step of New Drug Application (NDA) approval in order for the drug to be marketed.
    • Phase 4: Once the drug is marketed, the companies voluntarily or as per the requirement of the FDA will undertake post approval studies to validate and add additional information about the drug’s safety and efficacy.

    The third stage is known as Early-clinical stage in which the companies start initiating the phases of the testing and study. The first two phases mentioned above are what comes into this stage of Biotech companies. These companies that are in the first two phases are known as Early-stage biotech companies.

    The fourth stage is known as the late-clinical stage and the company is known as late-stage biotech. This stage consists of the regulatory approvals and NDA signing of the drug from the FDA.

    The fifth and final stage is the Commercial Stage, in which the companies have been approved for the NDA and begin rolling out the commercial strategies for the market. This stage also includes Phase 4 study as per requirement or voluntary basis.

    How to Invest in Biotech Stocks

    It may click to you up till this point that the biotechnology companies out there are in different stages of the Biotech lifecycle and thus have different risks associated with each stage for investment. The more progressed and approved the company is, in its stages, the more profitable and attractive its stock looks- however it still remains risky. Biotech Industry Organization (BIO) researched that the likelihood of success and regulatory approval to be received for a company from Phase I to Commercial stage has been 9.6% from data stretching 2006-2015. However, in the 2011-2020 data study, it was reduced to 7.9% which is mainly attributed to the concentration and new entrants in the market.

    The report also showed that even the hottest areas of a biotech investment portfolio which are Neurology, Cardiovascular, and Oncology have an approval rate of 8.4%, 6.6%, and 5.5% respectively. This report was also discussed by the Motley Fools team on their Youtube Channel in which they broke down the approval and success rating according to phases 1 to 4 (Commercialization), which was 70%, 33%, 30%, and less than 10% respectively.

    Failure is the big bad wolf in the biotech stock investment

    The investors need to lookout for the stage that the companies are in, in order to assess if the Biotechnology Company is worth investing into. Furthermore, it is important to heed for investors that companies can fail at any one of these stages which is what makes Biotech stocks volatile and risky. However, while looking into the track record of previous drug approvals of the company as well as the financials of the company, you can make a strong investment. The opposite is also true, once the company has been approved for any one of these stages and progresses, the stock price shoots up to double and triple digit percentages, while in some cases it can shoot up to quadruple digit percentages!

    Other proven ways to invest in Biotech Stock

    Looking at one biotech company’s stock for investment may seem to be tricky sometime, if there aren’t enough indicators to decide if the stock is valuable or not. In cases like these, especially if you are a new investor looking for exposure into the Biotech Industry, the safest bet is to opt for Exchange Traded Funds (ETFs) for biotechnology stocks. Biotech ETFs provide a great space for a new investor to get an exposure into Biotech stocks. Depending on your curiosity and preference you may opt for an equal-holding weight ETF or a market weighted ETF. The former will give you equal exposure to small new biotech stocks as you would get from big blue chip Biotech stocks.

    Another great strategy that has been evolving in the Biotech stock investment is the focus on Contract Research Organizations. Many Biotech stocks discover an idea for their drug candidate and then proceed to outsource the administrative, regulatory, experimentation, and clinical procedures to a CRO which is well equipped for exactly this sort of specialization in the Biotech space. These CROs generate revenue for their services despite the approval or disapproval of the product in any of the stages. Furthermore, big-fish CROs focus on the M&A action where they realize the potential of a new product candidate for which it merges, acquires or partners with the product’s Biotech company and reaps the gains from owning the candidate through its development and approvals. Therefore, investing in Biotech CROs may prove to be a better investment than just the developing Biotech Companies.

    Biotech Penny Stocks under $1

    A great way to start exposing yourself to Biotech stocks is to find biotech penny stocks which are $1 or under. Usually, investors invest in multiple under $1 portfolios to broaden their exposure. Here is a list of Biotech Penny stocks under $1.

    Ticker Company Market Cap Performance (YTD) Price Change
    AEZS Aeterna Zentaris Inc. 109.74 106.82% 0.88 2.11%
    ACST Acasti Pharma Inc. 116.17 71.54% 0.56 -1.24%
    ADXS Advaxis, Inc. 85.82 66.91% 0.58 23.31%
    ZSAN Zosano Pharma Corporation 95.38 64.01% 0.86 -3.94%
    OGEN Oragenics, Inc. 78.24 48.33% 0.67 -1.33%

    Biotech Stocks under $5

    Similarly, if you want to upgrade your investment portfolio from $1 biotech stocks, investors opt for bigger share price and market cap range for their portfolio and as such, focus on $5 or under Biotech stocks to invest in. This adds slightly more reward and risk but still provides great exposure.

    Ticker Company Market Cap Performance (YTD) Price Change
    SESN Sesen Bio, Inc. 755.67 203.70% 4.10 -3.53%
    PTIX Protagenic Therapeutics, Inc. 38.77 152.38% 2.65 -1.85%
    CTXR Citius Pharmaceuticals, Inc. 353.83 111.76% 2.16 0.47%
    MRKR Marker Therapeutics, Inc. 234.82 89.66% 2.75 -1.79%
    OTLK Outlook Therapeutics, Inc. 441.29 86.15% 2.42 1.68%
  • 30+ Best Performing Stocks in Last 10 Years

    30+ Best Performing Stocks in Last 10 Years

    Investing in stocks is quite risky but actually, it is not that risky if you have long-term prospects. The thing which matters the most is your research and knowledge about that particular stock in which you want to invest.

    There is a myth that the stock market is a gambling game and that’s why most people feel shy to make their own decisions regarding purchasing the shares of the particular stock without the advice of a broker or someone else.

    Detailed analysis of company fundamentals, balance sheet, its growth over the years, and developments make it easy for the investor to decide whether to buy the shares of that particular stock or not.

    Let’s talk about five best performing stocks today that showed impressive growth over the last ten years.

    Top 5 Best Performing Stocks in the Last 10 Years

    1. Tesla, Inc. (TSLA)

      The number one best performing stock we have on our list is Tesla (TSLA). The United States-based company is engaged in the development of Electric vehicles and energy generation.

      Tesla has shown extraordinary growth over the last 10 years and generated billions of dollars over the years.

      The last fiscal year’s revenue for the company was close to $36 billion representing a more than 38% increase over the year.

      The TSLA stock value has improved by approximately 10,145% in the last decade which is breathtaking indeed.

      So, if you had invested $1000 in Tesla stock in May 2011, you would have approximately $102,459 in 2021.

      It is an undeniable fact that Tesla CEO Elon Musk had put a great effort to achieve this success. He made impossible things possible and bravely faced criticism.

      In an event of revealing Model S beta in 2011, a vehicle that could go from 0 to 60 mph in 4.5 seconds, Musk replied to the criticism of oil companies by saying.

      “You had the opportunity to ride a unicorn.”

      On February 9, 2012, the Model X prototype was revealed which got advance sales of more than $40 million. On June 22, 2012, Tesla made its first delivery of the Model S.

      In 2014, Autopilot hardware was added to Model S. In 2015, a giant battery for Home was revealed by Tesla. The first mass-market car prototype was introduced.

      Solar City was purchased worth $2.6 billion and Grohmann Engineering firm was also bought by Tesla. A Semi truck was introduced in 2017 which also had self-driving capabilities.

      In 2019, Tesla Model Y and Cybertruck were introduced. In 2020, Tesla Model S became the first electric vehicle to get an EPA-rated 400-mile range.

      Now, Tesla has a market cap of $555.4 billion and a cash balance of $19,622 million by the end of 2020.

    2. NVIDIA Corporation (NVDA)

      The second best performing stock in the last 10 years on our list is NVIDIA Corporation (NVDA). The company is mainly operating in two segments.

      One is Graphics and the other one is Compute & Networking. The recent fiscal year revenue for NVIDIA Corporation was $16,675 million which shows 52.73% growth over the year.

      NVDA stock has shown 3,258% growth in the last ten years. So, an investment of $1000 made in 2011 in NVDA stock converted to 33583$ in 2021.

      Since the company was founded in 1993, it was well established till 2011 as it shipped 1 billion graphic processors at that time.

      In 2012, it launched powerful Tegra 3-based tablets and smartphones. Tegra 4 family was introduced in 2013 by NVIDIA.

      Android gaming reached its peak in 2014 via the launch of TEGRA K1, SHIELD TABLET. NVDA stock made significant development in the areas of Artificial intelligence and deep learning.

      In 2017, the AI supercomputers were powered by Volta GPU architecture by NVIDIA stock. Computer graphics were reinvented by NVIDIA using Turing architecture NVIDIA.

      New Datacenters, autonomous vehicles, and pro graphics markets were introduced in 2019. NVIDIA Ampere GPU architecture was introduced in 2020.

      NVIDIA now has a market cap of $362.3 billion and had Cash & Short-Term Investments of $11.561 million by the end of January 2021.

    3. MarketAxess Holdings Inc. (MKTX)

      The third best performing stock in the last 10 years is MarketAxess Holdings Inc. (MKTX) stock.

      MarketAxess Holdings was founded in 2000 and currently is the leading trading platform for fixed-income securities.

      The MKTX stock generated 689,125 million revenue for the fiscal year 2020 and showed 34.77% sales growth over the year.

      The growth percentage for MKTXstock for the past ten years is 2201% which means that the investment of $1000 in 2011 has reached approximately 23013$ in 2021.

      Over the years, Market Access has built a strong and diverse workforce and supported many organizations in the COVID-19 area.

      The interesting thing about this stock is that its business model requires little capital and generates plenty of cash in return.

      The company has a current market cap of $17.2 billion and had total assets of $1,331 million by the end of 2020.

    4. Align Technology, Inc. (ALGN)

      The fourth best performing stock we had in the last 10 years is Align Technology, Inc. (ALGN). It is a medical device company founded in 1997.

      The company is engaged in the designing, manufacturing, and marketing of Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists.

      ALGN stock revenue for the fiscal year 2020 was $2,472 million representing yearly growth of 2.71%.

      Though the fiscal year 2020 performance was not that much high as the market focus was shifted to COVID-19 related stocks.

      But ALGN showed overall good performance over the last 10 years. ALGN stock grew by 2192% over the past 10 years.

      So, if you invested $1000 in 2011 in Align Technology stock, you would have $22918 million by May 2021.

      In 2011, the company acquired iTero intraoral scanner due to which more than 7.5 million restorative crown, bridge, and custom implant cases have been done so far and more than 10.2 million patients got treated by the company.

      The company has a large network as doctors from more than 100 markets around the globe use the Invisalign system and iTero scanners.

      ALGN stock has a market cap of $46.5 billion and had cash of $961 million at the end of 2020.

    5. Amazon.com, Inc. (AMZN)

      The fifth best performing stock in the last 10 years in our list is Amazon.com (AMZN).

      It is the world’s leading eCommerce platform where more than $17 million in sales occur in one hour according to recent estimates.

      AMZN stock recorded $386,064 million in revenue for the fiscal year 2020 and its sales growth increased by 38% over the year.

      The stock performance in the past 10 years is quite satisfactory as it grew by 1508%. So, an investment of $1000 in 2011 means $16076 in 2021.

      COVID-19 has greatly benefitted the eCommerce business, and this is the reason that AMZN sales growth increased significantly in the recent year and is likely to increase more in the future.

      The CEO of Amazon Jeff Bezos is the richest person on Earth so far having a net worth of $188.5 billion.

      The company has a market cap of 1.63 trillion and had Cash & Short-Term Investments of $84,653 million by the end of 2020.

    Top 30 Stocks of the Decade

    1. Meta Platforms

      Meta Platforms (META) is among the most phenomenal stocks, thanks to the impressive Quest 3 VR headset launch.

      With rave reviews, a sleek design, and an affordable starting price of $499, it outshines Apple’s costly offering.

      Trading at 20x 2024 EPS targets, Meta’s strong product roadmap and potential for profit make it an enticing investment in the booming Metaverse and AR/VR market.

    2. Netflix

      Netflix (NFLX) is a standout among the best performing stocks, with a remarkable 115% rebound. It remains undervalued despite its strong growth potential.

      With diverse content, a global audience, and a growing subscriber base, Netflix is set for double-digit revenue and EPS growth. Technical indicators signal further upside.

    3. Salesforce

      Salesforce (CRM) has become one of the best performing stocks today in the software space due to its ability to generate added value through strategic acquisitions, such as Tableau and Slack.

      Despite a conservative revenue outlook, their focus on profitability and projected 42% YoY growth in adjusted EPS make it an attractive investment. It trades at a relatively lower P/E ratio compared to peers like Microsoft.

    4. Alphabet Inc.

      Alphabet Inc. (GOOG) is among the best performing stocks due to smart acquisitions like YouTube, which now generates nearly $40 billion in revenue.

      Their cloud division, Google Cloud, is gaining momentum with positive operating income in 1Q23.

      Analysts suggest a potential valuation range of $1,635 to $1,850 billion, exceeding the current market cap of $1,576 billion. It’s a promising long-term investment.

    5. Microsoft

      Microsoft (MSFT) is among the best performing stocks today. Its dominance in AI is evident through investments in OpenAI and the integration of AI algorithms into its products.

      Analysts project a potential $100 billion revenue uplift in 2027. Despite its high valuation, the stock has upside potential, with a bull case price target of $440.

    6. Airbnb

      Airbnb (ABNB) stands out as one of the best performing stocks today. With its leadership in alternative accommodations, a strong brand, and a huge underpenetrated market, Airbnb has a significant growth runway.

      Its estimated fair value of $201 against its current price of $125 offers an undervalued investment opportunity.

    7. ON Semiconductor

      When it comes to investing in the automotive semiconductor market, ON Semiconductor (ON) stands out remarkably.

      With a wide range of solutions for electric vehicles (EVs) and a leading position in silicon carbide technology, ON is positioned for growth.

      They target a sales CAGR of 10-12% from 2022 to 2027, and their SiC-related solutions aim for a 70% CAGR. Exciting times are ahead!

    8. Academy Sports and Outdoors

      Academy Sports and Outdoors (ASO) is among the best-performing stocks despite a recent 25% price drop.

      With a Total Addressable Market (TAM) of $175 billion and a CAGR of 7.9%, ASO has immense growth opportunities.

      Its strong store growth plan, high store productivity, improved e-commerce, and focus on customer experiences contribute to its success. With a cheap valuation and a 50% upside potential, ASO is a compelling “Buy” opportunity.

    9. Texas Instruments

      Texas Instruments (TXN) has rewarded loyal shareholders by being a top performer in the last 10 years. Though the share price has been flat since 2021, this is common in a cyclical industry like semiconductors.

      With its #1 position in analog chips and impressive 25% CAGR dividend growth, TXN is a stable and profitable choice.

    10. Fanuc Corporation

      Fanuc Corporation (OTCPK: FANUY) is an intriguing stock pick. Despite a short-term earnings decline of -18.3% in FY 2023, its ROBOT division achieved remarkable +42% sales growth in FY 2022.

      Additionally, the FA division has growth opportunities in Europe and India. With a hold rating, FANUY offers long-term potential for investors.

    11. PayPal

      PayPal (PYPL) is one of the best performing stocks today.

      Its strong business model with over 35M merchants and 400M consumers, along with its branded checkout and payment processing services, make it an attractive long-term investment.

      In Q1 2023, it had $63 billion in total payment volume and 190 million monthly active users.

      With its market leadership, growth potential, and recent cost reduction initiatives, PayPal offers an enticing opportunity for investors.

    12. Walt Disney

      Walt Disney (DIS) is among the best performing stocks due to its strong assets and long-term prospects.

      Despite a weak stock performance and a higher valuation compared to peers, the company’s forward PEG ratio of 1 shows some balance.

      While facing challenges such as the CFO exit, box-office performance, writers’ strike, and overall content costs, Disney’s focus on its parks and experiences can drive revenue and support the company’s turnaround.

    13. Alibaba

      Alibaba’s (BABA) cloud division, despite a recent 2% decline in revenue, has shown potential with a past 62% YoY growth rate. The upcoming spinoff and increased management focus indicate a brighter future.

      With a valuation that seems favorable, Alibaba stock presents a good growth option, especially considering the possibilities of its cloud division.

    14. Ford

      Ford Motor Company (F) has shown strong growth potential with a recent 20% month-over-month surge.

      Factors supporting its stock include decreasing U.S. credit risk, a positive inflationary environment, efficient operational performance, and government support for its electric vehicle segment.

      With undervalued valuation metrics and a dividend payout, Ford’s stock appears promising for investors.

    15. Duke Energy

      Duke Energy (DUK) is one of the best performing stocks today, with a strong track record of dividend growth and steady financials.

      Revenue increased by nearly 30% in the past decade, and the company aims for 5%-7% annual EPS growth. With a current dividend yield of 4.5%, Duke Energy offers stable income and potential for future growth.

    16. CleanSpark

      CleanSpark (CLSK) is a top-performing stock with a focus on clean Bitcoin mining and advanced energy solutions. Recent acquisitions have added a significant hash rate at a great value point.

      Q2 2023 revenue of $42.5 million, increased mining output, and undervaluation compared to peers make CleanSpark an attractive investment choice for potential growth.

    17. Kratos

      Kratos Defense & Security (KTOS) shines as one of the best-performing stocks. Positioned to benefit from combat drones, KTOS offers exposure to expanding defense sectors and potential long-term upside.

      With projected 2023 sales of $220-225 million and improving margins, it’s an exciting investment for those looking for growth and profitability.

    18. Axcelis Technologies

      Axcelis Technologies (ACLS) has skyrocketed an impressive 2,400% in the last decade, thanks to its strong financial performance.

      With a 19% revenue CAGR, excellent profitability, and resilient growth momentum, ACLS is a compelling buy.

      Despite a recent rally, the stock’s potential for double-digit revenue growth and solid balance sheet position it for further success.

    19. DuPont de Nemours

      DuPont de Nemours (NYSE: DD) shines as a top-performing stock with diverse revenue streams and a growing healthcare business.

      Although currently overvalued with a low dividend yield, patient investors can wait for a pullback to around $57 for a 2.5% yield. Watch for promising growth in DuPont’s healthcare sector and potential long-term returns.

    20. InfuSystem Holdings

      InfuSystem Holdings, Inc. (NYSE: INFU) has seen a strong price surge of ~23% since November, indicating good returns in a short time.

      Re-inclusion in the Russel 3000 index triggered significant buying, and partnerships with GE Healthcare have fueled revenue growth.

      However, caution is advised as operating profit has declined gradually. Hold INFU for potential gains.

    21. Cameco Corporation

      Cameco Corporation (CCJ) is a top-notch stock of the decade due to its expanding nuclear business. It supplies uranium to electric utilities worldwide and recently acquired 49% of Westinghouse Nuclear.

      With uranium prices doubling since the 2020s and positive financial performance, CCJ is well-positioned to benefit from the growing demand for nuclear power.

    22. Broadridge Financial Solutions

      Broadridge Financial Solutions (BR) is another top-tier stock on our list.

      With robust revenue growth and increasing profitability, it has delivered a remarkable 988% total return since 2007.

      Despite a premium valuation, its comprehensive data provision and trade processing services position it for continued growth and potential returns for investors.

    23. Arch Resources

      Arch Resources (ARCH) is among the best performing stocks today due to its solid financials.

      With Q1 adj. EBITDA of $277 million and beating sales volume estimates, the company showcases resilience in the coal market.

      Their commitment to shareholder returns is evident with a quarterly DPS of $2.45 and a net cash position of $70 million.

      With a low EV/EBITDA multiple and a positive outlook for met coal, Arch is positioned for long-term growth.

    24. Nike

      Nike (NKE) is an incredible stock with a strong brand and competitive advantages. Their hyped sneakers and collaborations showcase pricing power.

      Despite temporary challenges, they maintain a 10% profit margin, generate $3.79bn in free cash flow, and have a robust balance sheet. Buying at a discounted price presents long-term growth potential.

    25. Altria Group

      Altria Group, Inc. (MO) is a great stock due to its consistent improvement in assets and cash flow, despite warnings about cigarettes.

      With a single-digit P/E, strong financials, and a dividend yield of over 8%,  Altria offers valuable long-term investment potential.

      The company’s targets for earnings and dividend growth, along with its focus on smokeless products, further support its positive outlook.

    26. Coca-Cola Consolidated

      Coca-Cola Consolidated (COKE) stands out as one of the best performing stocks today with a 4x outperformance compared to the S&P 500.

      With strong fundamentals, impressive margins, and a 12% increase in sales, COKE proves to be an attractive investment, despite its low dividend yield.

    27. JD Sports

      JD Sports (OTCPK: JDSPY) stands tall among champion stocks in the UK market, delivering impressive returns.

      Despite its physical retail presence, JD Sports thrives on the demand for sportswear, global expansion, and its omnichannel strategy.

      Its revenues of £10 billion and profits of £226 million in its latest year, poise it for continued growth.

      With strong financial performance, ambitious growth plans, and an attractive valuation, JD Sports offers good value for investors.

    28. Adobe

      Adobe (ADBE) is among the best performing stocks today due to its impressive financial performance and growth prospects.

      With Q1 revenue up 9.4% YoY and solid operating leverage, the company is gaining a share in the creative software market.

      While the valuation is fair, its long-term positive outlook makes it a strong contender for investment.

    29. Gerdau S.A.

      Gerdau S.A. (GGB) is a leading long steel producer in the Americas and has emerged as one of the best performing stocks today.

      Despite recent underperformance, its low P/E multiple and strong dividend issuance make it attractive. With improving profitability and a 23% FCF yield, Gerdau offers great value.

      Its sustainable practices and diverse operations add to its appeal. Invest with confidence!

    30. Zscaler

      Zscaler (ZS) stands out as one of the best performing stocks today. With its cybersecurity solutions in high demand, the company addresses the critical need for secure cloud access.

      Zscaler’s impressive revenue growth of 52% YoY and solid customer expansion highlight its market presence.

      Despite the heavy investment in R&D and stock-based compensation, the company’s strong financial position and promising future profitability make it an attractive investment for growth portfolios.

    Lessons and Insights from The Best Performing Stocks

    It is important for investors to discover the valuable lessons and insights derived from the remarkable success of the best performing stocks over the past decade.

    Lessons and Insights from The Best Performing Stocks

    We have listed some of these lessons below to gain a deeper understanding of the factors that have propelled these stocks to greatness in this informative and engaging section:

    • Embrace Innovation

      The best performing stocks of the past decade have consistently embraced innovation. Investing in companies at the forefront of technological advancements can yield significant returns.

    • Tech is King

      Technology has been a driving force behind the success of many top stocks.

      From artificial intelligence and cloud computing to e-commerce and digital transformation, technology has reshaped industries and created enormous opportunities for investors.

    • Adapt to Market Dynamics

      Successful stocks have shown the ability to adapt to changing market dynamics. Flexibility, agility, and the ability to pivot strategies have been crucial for sustained growth.

    • Long-Term Perspective

      Many top-performing stocks have rewarded patient investors. Long-term thinking allows for riding out short-term volatility and capitalizing on the compounding effects of consistent growth.

    • Focus on Quality

      Quality companies with strong fundamentals and competitive advantages tend to outperform in the long run.

      Thorough research, analyzing financials, and understanding the company’s unique value proposition are essential.

    Common Characteristics Among the Top Performing Stocks

    So, you might be wondering, what sets the crème de la crème of stocks apart from the pack? Worry not, because we have you covered.

    One essential factor is a strong leadership team, guiding the company with vision, strategic acumen, and a track record of success.

    These stocks often thrive in industries poised for significant growth, capitalizing on emerging trends and consumer demand.

    Another crucial aspect is commanding market share, establishing a dominant position that offers a competitive edge.

    Additionally, strong sales growth reflects their ability to capture market demand and generate consistent revenue.

    This is true for the best performing penny stocks as well, which are typically prone to volatility. Lastly, a large target market provides ample room for expansion and sustained profitability.

    Uncover these winning traits and set yourself on the path to investment success in this thrilling era of possibility.

    Risks and Considerations

    When seeking to invest in the top stocks of the last decade, it’s important to keep in mind the following risks:

    Risks and Considerations

    • Past Performance ≠ Future Performance

      Just because a stock performed exceptionally well in the past doesn’t guarantee it will continue to do so in the future. Market conditions can change, and new winners may emerge.

    • Market Dynamics Evolve

      The last decade may not resemble the next one. Industries and trends shift, and what worked before might not be as successful moving forward. Keep yourself informed and shift the gears of your investment strategy accordingly.

    • Economic Uncertainty

      Economic downturns and recessions can impact even the strongest stocks. Consider the broader economic landscape and how it might influence the performance of your chosen investments.

    • Disruptive Innovations

      Technological advancements and disruptive innovations can reshape industries overnight. Keep an eye on emerging technologies and how they might disrupt the market landscape.

    • Competitive Landscape

      The competitive environment can shift rapidly, with new players challenging incumbents. Assess the competitive landscape of the stocks you’re considering to understand the potential risks of losing market share.

    The Importance of Diversification and Ongoing Analysis

    Let’s talk about two essential elements in your investment journey: diversification and ongoing analysis. These are your most crucial tools for the investing game, always ensuring your financial well-being.

    Diversification is like spreading your investment eggs across different baskets. It helps protect you from the ups and downs of individual stocks or sectors.

    The Importance of Diversification and Ongoing Analysis

    By diversifying, you can balance potential gains and losses and reduce the impact of any single investment’s performance.

    Also don’t forget about ongoing analysis! Stay curious, and stay informed. Keep an eye on market trends, industry news, and how your investments are doing.

    Regularly analyzing your portfolio lets you identify any underperformers and make adjustments as needed.

    So, embrace diversification and keep that analysis engine running for a more resilient and rewarding investment strategy. These are critical to consider in your search for the best performing stocks of all time.

    Conclusion

    Congratulations, investor! You’ve journeyed through the fascinating realm of the best performing stocks of all time, uncovering valuable lessons and insights along the way.

    Remember, innovation, technology, and adaptability are key drivers of success. Be cautious of risks and understand that past performance doesn’t guarantee future results.

    Embrace diversification, spread those investment eggs wisely, and stay on top of ongoing analysis.

  • 7 Biotech Stocks to Buy in 2021

    7 Biotech Stocks to Buy in 2021

    Change is inevitable in every aspect of life because it results from human exploration and applying knowledge to improve life quality. This is why many industries have shown significant growth with time, and the biotech industry is one of them. The biotech industry has extraordinarily impacted healthcare, biological science, economy, and business in recent years. The plethora of biotech stocks continuously put their efforts into developing therapeutics and vaccines that are effective and less toxic, and easily accessible for individuals. With the rise of COVID-19, the Biotech industry has gained more importance. Many biotech stocks have developed and commercialize vaccines in the battle against the deadly pandemic. Now many investors are looking for biotech stocks to get high profits in the future. Here are the 7 biotech stocks to buy in 2021.

    Pfizer (PFE)

    The first and foremost stock to watch in 2021 is Pfizer (PFE), one of the first biotech stocks to market the COVID-19 vaccine. Since then, it has contracted with many governments and supplied millions of doses and looking forward to providing more than this in the future. The U.S government has a plan to vaccinate all of its adult population, and Pfizer is likely to contribute a lot to this cause. While many other biotech stocks only focus on older patients, Pfizer is also developing a COVID-19 vaccine for children, which is another positive sign for future growth. The company has a market cap of more than $220 billion and annual revenue of more than $40 billion. Hence Pfizer stock can be a good bet in 2021. 

    Regeneron Pharmaceuticals (REGN)

    The second stock that could prove fruitful for investors in 2021 is Regeneron Pharmaceuticals(REGN). The company has a market cap of more than $55 billion and is engaged in discovering, developing, and manufacturing various therapeutics to treat medical conditions worldwide. One of the two authorized antibody treatments to treat COVID patients belongs to Regeneron. Its recent first-quarter results show that its quarterly revenue showed 38% growth year over year. Its COVID-19 antibody treatment alone generated $262 million in the first quarter of 2021. Besides this, Eylea, a drug to treat eye diseases, also impacts its increased sales over time. Hereafter, investors need to keep an eye on this stock.

    Novavax (NVAX)

    On Number three, we have Novavax (NVAX). It is another biotech stock engaged in the development of commercialization of vaccines to prevent infectious diseases. Novavax has significantly outperformed in the COVID-19 era and still giving a tough time to its competitors. Its COVID-19 vaccine candidate NVX-CoV2373 could bring massive profits in the future. Novavax is about to finalize the major supply deal with the European Union, which means the supply of 500 million or more doses. So, a lot of money on the line is expected for Novavax stock. 

    Moreover, it has also inked supply deals with many countries in which India is also included, which has more than 1.3 billion population. Novavax generated a breathtaking $447 million in revenue in the first quarter of 2021 compared to $3 million in the same quarter of last year. This significantly increased revenue shows its success over the year. In a nutshell, investors should keep an eye on this stock.

    Bio N Tech SE (BNTX)

    On Number four, we have Bio N Tech (BNTX), which is a biotechnology company engaged in discovering and developing therapeutics to treat various infectious diseases. Bio N Tech is the partner of Pfizer in the battle against COVID-19. BNTX stock expects $26 billion in sales for the COVID-19 vaccine and its partner in 2021 and estimates roughly $3 billion in earnings. Millions of the mutually prepared COVID-19 vaccine doses have been delivered to many countries so far. Both partners are negotiating with many other countries to supply COVID-19 vaccine doses worth $3 billion by 2022, which points to the bright future of BioNTech stock. So it can be a good bet for investors in the future.

    Ocugen (OCGN)

    Ocugen (OCGN), stands at number five on our list. It is a clinical-stage biopharmaceutical company focused on developing therapeutics to cure blindness and other retinal diseases. Ocugen stock is working with Bharat Biotech to develop COVAXIN and the vaccine used to treat COVID patients. The phase-3 study results of COVIXIN showed 100% efficacy against severe coronavirus and 78% efficacy against mild and moderate COVID-19 disease. The Indian government has given emergency use authorization to Bharat Biotech which is a positive sign for Ocugen stock. Ocugen stock is looking forward to developing the COVID-19 vaccine for other markets and can be a good bet for investors in the future.

    Seagen (SGEN) 

    Seagen Inc is an American-based biotech stock focused on developing and commercializing therapeutics to treat cancer patients, and it’s in the Number six position on our list. Seagen has shown significant growth in 2020 as compared to 2019. Its revenue for 2020 totaled $2.2 billion, which shows 140% growth over the year. The revenue for the year 2019 was $916.7 billion. The company has achieved global success with Adcetris, an antibody medicine used to treat lymphoma, and is in an excellent position to invest more in developing newer medications. Therefore, Seagen is one of the biotech stocks to watch in 2021.

    Vertex Pharmaceuticals (VRTX)

    The seventh biotech stock to watch in 2021 is Vertex Pharmaceuticals Incorporated (VRTX), which is mainly focused on developing and commercializing therapeutics to treat cystic fibrosis. Trikafta is the most important drug of Vertex pharmaceutical that treats roughly 90% of patients with cystic fibrosis. Estimates show that 70,000 cystic fibrosis patients are there globally, and Trikafta is the only medication available for this disease. Vertex stock has generated significant revenue through Trikafta and some other products, which will continue to rise in the future. The company has partnered with CRISPR Therapeutics and announced impressive results from a clinical trial of gene therapy for two rare blood diseases. Consequently, its continued success against cystic fibrosis and clinical developments suggests that this stock could outperform in the long run.

    The following three biotech stocks are with the lowest 12-month trailing price-to-earnings ‎ratio (P/E). Dividends and buybacks are two ways a company can return profits to ‎shareholders, so a low P/E ratio shows you are paying less for every dollar of profits ‎generated.

    The Agios Pharmaceuticals (AGIO)‎

    The Agios Pharmaceuticals Inc. platform is a pharmaceutical company dedicated to ‎developing drugs for genetic diseases such as hemolytic anemias and sickle cell disease. In Q1 ‎‎2021, the company reported a net income of $1.9 billion, a far cry from its Q1 2020 loss. ‎Agios’ oncology portfolio was sold to Servier Pharmaceuticals LLC in the first quarter, which ‎had an impact on revenue.

    Sage Therapeutics, Inc.. (SAGE)

    Sage Therapeutics has developed treatment for issues related the central nervous system, including schizophrenia and major depression. The company reported positive results from its SAGE-718 clinical trial, a drug that may be used to treat Huntington disease, in Q1 2021.

    Innoviva Inc. (INVA)

    Innoviva is a healthcare-oriented asset manager that holds portfolios of royalties for many pharmaceuticals.

  • Top 5 Dividend Stocks To Watch in 2021

    When someone wants to invest in a particular stock, a common question comes in the mind. Whether the stock pays the dividend or not. It is because the dividend is the source of passive income. Moreover, it gives you a general idea about the company’s performance.

    If you are new to stocks, you might be thinking about what actually the dividend is. Informally dividend is the thank you gesture to its loyal shareholders in the form of cash or shares. Formally, a Dividend is the part of the money or additional shares that a company gives regularly to its shareholders from its profits. But it is not mandatory for the company to pay a dividend. The company’s board of directors decide whether to give dividend or not. Here are few things that you need to know about the dividend.

    Declaration Date: It is the announcement date of the dividend.

    Ex-Dividend date: It is the date on or after which the buyer of the stock is not eligible to get the dividend.

    Date of Record: It is the date on which a company identifies its shareholders.

    If you want a dividend, you must have to purchase stock two days before the date of record.

    Now we will discuss the top 5 monthly paying dividends stocks that we have picked for you.

    Pembina Pipeline Corporation (PBA)

    Let’s start with stock number 5 which is Pembina Pipeline Corporation with the ticker symbol PBA. It is the leading energy transportation and midstream service provider for more than 65 years. The company owns pipelines that transport hydrocarbons and natural gas products. The company has an 18.15-billion-dollar market cap. Its shares have climbed more than 37% in the past 12 months. First-quarter 2021 revenue grew by 22.38% over the year. Pembina has a 3.38% dividend yield which is relatively good in the covid era. Its three-year dividend growth rate is 18.79% and almost  53% payout ratio based on cash flow. Why this stock is good because oil and gas are the need of almost every segment of life. As the global economy is in the recovery phase, the demand for oil and gas will increase. This change will have a positive impact on Pembina Pipeline. Furthermore, its earnings per share for the second quarter of 2021 are estimated to be increased by 42.88% year over year. So based on these facts, we can say that this low dividend yield stock is less risky as compared to other industry peers.

    Prospect Capital Corporation (PSEC)

    Prospect Capital Corporation, which trades with ticker symbol PSEC, is on number 4 in our list of monthly paying dividends stocks. It is a business development company that provides financing to middle-market companies. The company has a 3.45-billion-dollar market cap and is doing business in 39 industries. Its portfolio is mostly debt-based and expanded to more than 120 companies. The company’s shares reflect almost 70% growth over the last year which is a good sign. Prospect Capital has quite a high dividend yield of 8.08% however, its dividend has not shown growth in the last three years. The stock is appealing in terms of monthly dividends due to its income potential. As it operates by financing middle-market companies in various industries ranging from candle makers to IT service providers, it generates consistent revenue and pays high yield dividends to its shareholders. Its shares are climbing significantly in this year and therefore it can pay you high dividends along with handsome profits.

    AGNC Investment Corp (AGNC)

    The third monthly dividend stock that we have picked for you is AGNC Investment Corporation with the ticker symbol AGNC. It is a real estate investment trust company that mainly invests in mortgage-backed securities instead of physical real estate. Due to this reason, AGNC stock is appealing to many investors. The company has a market cap of 8.96 billion dollars. Its shares increased by 33.15% over the last 12 months. By the end of March 2021, the company had a 90.3 billion dollars investment portfolio which is quite massive. The company has made a great comeback in 2021 after an ordinary performance due to covid-19. Its first-quarter 2021 revenue and income surged by more than 140%. So it means that the AGNC stock is now on its way to grow. AGNC dividend yield is 8.44% and the payout ratio is 29.86%. Due to its massive mortgage-backed portfolio, the rising interest rates do not affect the company’s business rather it benefits AGNC. Moreover, the current financial condition is favorable for the company to enhance its portfolio. So based on its safe business nature and financial condition, this stock can prove to be fruitful to you in the future.

    STAG Industrial, Inc. (STAG)

    The stock number two in our list of monthly dividend stocks is the STAG industrial Incorporation with the ticker symbol STAG. It is the real estate investment trust company acting as the lead in the light industrial and logistic properties. The company has more than a 6 billion market cap. its portfolio is spread across 39 states of the U.S. Approximately 40% portfolio belongs to e-commerce activity and Amazon is its biggest tenant. The company owns 494 buildings covering 99.1 million square feet of area. So you can now imagine how large a portfolio we are talking about.

    STAG shares rose almost 35% over the past year. This shows that the company performed exceptionally even in the pandemic era. Its dividend yield is 3.80% and 2.49% three-year dividend growth rate. The payout ratio based on cash flow is 52.11%. Its dividend track record is quite attractive as it is consecutively growing for the last seven years. Its quarterly revenue has been increased 13% over the year. A 16% projected increase for the second quarter of 2021 is a good sign for investors. Now you must have got an idea why this stock is good for you. Furthermore, this stock is safe and consistent so if you are too shy to come out of your comfort zone in terms of investment in stocks, STAG Industrial will suit well to you.

    Realty Income Corporation (O)

    Realty Income Corporation is another dividend-paying stock to watch in 2021. It is a real estate investment trust company. Although several companies pay monthly dividends, this company is well known for its monthly dividends. That’s why it actually trademarked “The monthly dividend company “ as its official nickname. The companies diversified portfolio includes 6600+ properties and 56 retail and other industries. The company is dealing with more than 600 clients across 50 states, Puerto Rico, and the United Kingdom. Its share jumped 13.39% over the past year. The first-quarter revenue represents almost 7% positive change. The dividend yield for the Reality Income is 4.18%. The three-year dividend growth is 10.41%. Since its listing, it has paid 611 consecutive dividends to its shareholders. The dividend is growing consecutively for the past 27 years which is not an ordinary thing. Even in the pandemic era, its diversified portfolio and discipline helped to maintain the dividend growth streak. Now the economy is coming back to life, we expect that its affected tenants like cinema operators and gyms will be in much better shape financially.

  • Is Tesla, Inc. (TSLA) stock good for you in 2021?

    Is Tesla, Inc. (TSLA) stock good for you in 2021?

    It is estimated that the global electric vehicle market is going to grow with a 29% compound annual growth rate (CAGR) in the next five years. So, it is obvious that the companies working in the manufacturing of electric vehicles, battery, and energy storage would show significant growth in the future and Tesla (TSLA) stock is the leading company among them.

    Tesla, Inc. (TSLA), founded in 2003, is primarily working in the designing, developing, and manufacturing of electric vehicles in the United States and across the globe. TSLA stock is currently trading with $616.00 per share price, having an average trading volume of 30,955,950 shares a day and a market cap of $595.039 billion. Let’s take a closer look at Tesla stock.

    Tesla Business in China:

    Though the certain restriction in China has affected the Tesla business to some extent, analyst’ estimates show that the overall electric vehicle sales in China would likely increase by 5% to 10% in the next 10 years and acting as the major contributor in the manufacturing of electric vehicles, Tesla stock would get the maximum benefit in the future. According toChina Passenger Car Association (CPCA), Tesla delivered 33,463 vehicles in May 2021 representing a 295 monthly jump. Tesla delivered About 185,000 vehicles in the first quarter of 2021.

    Performance in Covid-19:

    In the pandemic era, Tesla stock sold about half a million cars across the globe which is not a usual number in the era where the cars were parked in the garage due to imposed covid-19 restrictions by governments. One analyst has projected Tesla deliveries to be more than 850,000 in the year 2021 which is far more than 500,000 deliveries in the last year.

    First Mover Advantages:

    TSLA stock has 25,000dedicated Supercharger stations installed and also leading in the manufacturing of autonomous vehicles as it has collected 3 billion miles of driving data as of March 2020 which is 150 times more than the data collected by Alphabet’s Waymo. Besides this, Tesla CEO Elon Musk is smart enough to devise the strategies in order to leverage the business.

    Financial View of Tesla stock:

    In the first quarter of 2021, TSLA stock reported $10.39 billion in revenue representing a 74% increase over the year. Earnings per share have surpassed the estimates of 73 cents per share to reach 93 cents per share and the net income of  $438 million was generated in the recently reported quarter.

    Future Plans:

    The new version of the Model S sedan has started to deliver in May 2021 and Model X deliveries will initiate in the third quarter of 2021. Furthermore, Tesla is also planning to launch an autonomous ride-hailing network in the future that could result in$1 trillion profit by 2030 according to Cathie Wood, CEO, and founder of Ark Invest.

    Competitor Analysis:

    TSLA stock is now facing a great rivalry in the automobile industry as companies like General Motors (GM), Ford, Inc (F), and Volkswagen are spending billions in the manufacturing of electric vehicles. These companies are well established and have a decade of experience in the automobile industry. Furthermore, BYD, Nio, and Xpeng are giving tough times to Tesla stock in the Chinese electric vehicle market via investing heavily in order to increase their market share. Another weak point of Tesla stock is that its share in the global market is less than 1% which is still very low as 70 million to 80 million new cars have been sold every year.

    Conclusion:

    For most of Tesla’s business, it has been unprofitable for investors but its performance in the last few years is exceptional. Though it is acting the lead role in the manufacturing of electric vehicles still it has a low global market share in the automobile industry. If it goes with the current pace, it will generate a lot of revenue in the future but investors should keep in mind that Tesla alone is not playing in the industry as many well-established EV stocks are present in the play.

  • Is Apple Inc. (AAPL) stock attractive in 2021?

    Is Apple Inc. (AAPL) stock attractive in 2021?

    We are living in an era where smartphones, tablets, computers, and laptops, etc. have now become the necessities of every single house. Imagine a life without a smartphone and you will find yourself to be non-functional without it. Evolution in information technology has given rise to the invention of many new digital devices and companies like Apple Inc. (AAPL) Stock, Sony Group Corp (SONY), Dell Technologies Inc (DELL), and many others have greatly contributed to this development. Apple alone has introduced many devices till now ranging from personal computers to smartwatches.

    So, it is very natural to think of investing in AAPL stock for a long-term gain prospect as it has shown significant growth over time and has earned a large number of profits over the years. In the last five years, the shares of Apple Inc. (AAPL) skyrocketed almost 419%. Apple Inc. (AAPL) is currently trading with $130.39 per share on June 15, 2021, as of this writing. Let’s take a closer look at Apple stock.

    Apple’s iPhone 12 Series & VR/AR Development:

    The iPhone 12 series which also supports the 5G technology is playing a major role in steadily growing AAPL stock price and estimates by the suppliers show that the 230 million iPhones could be shipped in the year 2021.iPhone 12 series is not alone major contributor in the company’s future growth as Apple’s VR/AR and mixed reality headset will be launch in the upcoming year with a hefty price tag of $3,000 with Apple pair of AR glasses to follow in 2025.

    Apple’s Services Business:

    Besides Apple’s hardware products, the stock is doing smart business in its services segment. In order to expand its audience across the globe, the AAPL stock has launched  Apple News+, Apple TV+, and Apple Fitness+ in the past couple of years which resulted in the $33 billion revenue in the first half of 2021 representing 25% growth over the year.

    Electric Vehicle Development:

    The big tech company is also paying attention to the development of electric vehicles as it is discussing supply deals with certain Chinese battery companies and the first electric vehicle by AAPL stock is expected to be launch between 2024 to 2026 according to analyst’s suggestion, which could prove to be the game-changer for the giant tech stock.

    Financial View of the AAPL stock:

    AAPL stock sales have been increased by 54% in the second quarter of the fiscal year 2021 representing a 66% improvement in the revenue gained from the iPhone over the year. Earnings per share increased by 119% in the recently reported quarter and $24 billion was recorded for operating profit out of which $23 billion was given back to the shareholders through share repurchases and dividends.  The quarterly payout was increased by 7% and the business is strengthened by the addition of $90 billion in the existing share repurchase plan.

    Wrap Up:

    Apple Inc. (AAPL) has captivated investors for decades and earned huge profits for them over time. Its evolutionary iPhone 12 series, VR/AR headsets, and upcoming pair of AR glasses show that the future is bright for Apple Inc. (AAPL). The significant increase in the services business is another positive sign for the giant tech stock. In a nutshell, long-term investment prospects are bright for AAPL stock.